to determine if patients with iddm have increased sensitivity of cellular beta 2-adrenergic receptor-effector systems , we assessed beta 2-adrenergic receptors and adenylate cyclase sensitivities to isoproterenol in partially purified mononuclear leukocyte ( mnl ) plasma membranes from 10 patients with iddm ( without adrenergic neuropathy ) and 10 matched nondiabetic controls .
C0001643
beta 2-adrenergic receptors
C0007603
plasma membranes